<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>11412656</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Casabona, N M</dc:author>
<dc:author>Caylà, J A</dc:author>
<dc:type>Letter</dc:type>
<dc:language>es</dc:language>
<dc:date>2001 May 05 </dc:date>
<dc:title xml:lang="es">Hay que añadir un cuarto fármaco a la pauta actual de tratamiento de la tuberculosis inicial?</dc:title>
<dc:title xml:lang="en">[Is it necessary to add a fourth drug to the initial treatment of tuberculosis?].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
